Faqian Bu

Recent Progress on Tubulin Inhibitors with Dual Targeting Capabilities for Cancer Therapy

Shuai Wen, Guan Wang, Yiwen Zhang et al. · Journal of Medicinal Chemistry · 2021 · 137 citations · Full text

Medicine, Oncology, Pharmacology +17

Developing potent LC3-targeting AUTAC tools for protein degradation with selective autophagy

Junping Pei, Xiaoli Pan, Aoxue Wang et al. · Chemical Communications · 2021 · 85 citations

Life Sciences, Medicinal Chemistry, Molecular Biology +14

Discovery of Tyrosinase Inhibitors: Structure-Based Virtual Screening and Biological Evaluation

Guan Wang, Jin Li, Xiaoli Pan et al. · Pharmaceutical Fronts · 2022 · 38 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +17

Unraveling the Design and Discovery of c-Jun N-Terminal Kinase Inhibitors and Their Therapeutic Potential in Human Diseases

Yumeng Zhu, Shuai Wen, Min Zhao et al. · Journal of Medicinal Chemistry · 2022 · 31 citations · Full text

Pharmacy, Medicinal Chemistry, Molecular Biology +13

Discovery of Novel Indazole Chemotypes as Isoform-Selective JNK3 Inhibitors for the Treatment of Parkinson’s Disease

Shuai Wen, Faqian Bu, Yumeng Zhu et al. · Journal of Medicinal Chemistry · 2023 · 23 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +17